EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The luciferase-based in vivo protein–protein interaction assay revealed that CHK1 promotes PP2A and PME-1 interaction

Sana Ando, Keiko Tanaka, Maharu Matsumoto, Yuki Oyama, Yuri Tomabechi, Atsushi Yamagata, Mikako Shirouzu, Reiko Nakagawa, Noriaki Okimoto, Makoto Taiji, Koichi Sato, Takashi Ohama

Journal of Biological Chemistry · 2024

DOI: 10.1016/j.jbc.2024.107277 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Sana Ando und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Veterinary Pharmacology, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan. Hauptthemen laut MEDLINE: Protein Phosphatase 2, Checkpoint Kinase 1, Carboxylic Ester Hydrolases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, JST, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein phosphatase 2A (PP2A) is an essential serine/threonine protein phosphatase, and its dysfunction is involved in the onset of cancer and neurodegenerative disorders. PP2A functions as a trimeric holoenzyme whose composition is regulated by the methyl-esterification (methylation) of the PP2A catalytic subunit (PP2Ac). Protein phosphatase methylesterase-1 (PME-1) is the sole PP2Ac methylesterase, and the higher PME-1 expression is observed in various cancer and neurodegenerative diseases. Apart from serving as a methylesterase, PME-1 acts as a PP2A inhibitory protein, binding directly to PP2Ac and suppressing its activity. The intricate function of PME-1 hinders drug development by targeting the PME-1/PP2Ac axis. This study applied the NanoBiT system, a bioluminescence-based protein interaction assay, to elucidate the molecular mechanism that modulates unknown PME-1/PP2Ac protein-protein interaction (PPI). Compound screening identified that the CHK1 inhibitors inhibited PME-1/PP2Ac association without affecting PP2Ac methylation levels. CHK1 directly phosphorylates PP2Ac to promote PME-1 association. Phospho-mass spectrometry identified multiple phospho-sites on PP2Ac, including the Thr219, that affect PME-1 interaction. An anti-phospho-Thr219 PP2Ac antibody was generated and showed that CHK1 regulates the phosphorylation levels of this site in cells. On the contrary, in vitro phosphatase assay showed that CHK1 is the substrate of PP2A, and PME-1 hindered PP2A-mediated dephosphorylation of CHK1. Our data provides novel insights into the molecular mechanisms governing the PME-1/PP2Ac PPI and the triad relationship between PP2A, PME-1, and CHK1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Phosphatase 2Checkpoint Kinase 1Carboxylic Ester HydrolasesHumansPhosphorylationLuciferasesProtein BindingHEK293 Cells

Stichwörter der Autor:innen

CHK1DNA damageNanoBiT systemPME-1PP2A

Substanzen

Protein Phosphatase 2protein phosphatase methylesterase-1Checkpoint Kinase 1Carboxylic Ester HydrolasesCHEK1 protein, humanLuciferases

Autor:innen und Institutionen

  • Laboratory of Veterinary Pharmacology, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan.
  • Laboratory for Protein Functional and Structural Biology, RIKEN Center for Biosystems Dynamics Research, Yokohama, Kanagawa, Japan.
  • Laboratory for Cell-Free Protein Synthesis, RIKEN Center for Biosystems Dynamics Research, Kobe, Hyogo, Japan.
  • Laboratory for Computational Molecular Design, RIKEN Center for Biosystems Dynamics Research (BDR), Osaka, Japan; Drug Discovery Molecular Simulation Platform Unit, RIKEN Center for Biosystems Dynamics Research (BDR), O…
  • Laboratory of Veterinary Pharmacology, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan; Research Institute for Cell Design Medical Science, Yamaguchi University, Yamaguchi, Japan.
  • Laboratory of Veterinary Pharmacology, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan; Research Institute for Cell Design Medical Science, Yamaguchi University, Yamaguchi, Japan. Electronic…

Förderung

  • Japan Agency for Medical Research and Development
  • JST
  • Japan Society for the Promotion of Science
  • Government of Japan Ministry of Health Labour and Welfare
  • Ministry of Education, Culture, Sports, Science and Technology

Zitieren

APA

Ando, S., Tanaka, K., Matsumoto, M., Oyama, Y., Tomabechi, Y., Yamagata, A., Shirouzu, M., Nakagawa, R., Okimoto, N., Taiji, M., Sato, K., & Ohama, T. (2024). The luciferase-based in vivo protein–protein interaction assay revealed that CHK1 promotes PP2A and PME-1 interaction. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.107277

Vancouver

Ando S, Tanaka K, Matsumoto M, Oyama Y, Tomabechi Y, Yamagata A, et al. The luciferase-based in vivo protein–protein interaction assay revealed that CHK1 promotes PP2A and PME-1 interaction. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2024.107277

BibTeX
@article{Ando2024,
  author = {Ando, Sana and Tanaka, Keiko and Matsumoto, Maharu and Oyama, Yuki and Tomabechi, Yuri and Yamagata, Atsushi and Shirouzu, Mikako and Nakagawa, Reiko and Okimoto, Noriaki and Taiji, Makoto and Sato, Koichi and Ohama, Takashi},
  title = {The luciferase-based in vivo protein–protein interaction assay revealed that CHK1 promotes PP2A and PME-1 interaction},
  journal = {Journal of Biological Chemistry},
  year = {2024},
  doi = {10.1016/j.jbc.2024.107277}
}
Kostenlos starten →